摘要
本文应用免疫组化技术检测了36例未分化癌和恶性淋巴瘤难以区分病例的LCA(leukocyte commonantigen)和EMA(epithelial membrane antigen)表达情况。LCA(+)EMA(-)者,判为淋巴瘤;LCA(-)EMA(+)者,判为未分化癌。结果表明:过去诊断为未分化癌和未分化癌、恶性淋巴瘤待排的5/18例,诊断修正为恶性淋巴瘤;过去诊断为类型未定的恶性肿瘤3例确诊为恶性淋巴瘤。
Thirty-six cases diagnosed histologically as ML or anaplastic carcinoma werereexamined immunohistochemically by leukocyte common antigen(LCA)and epithelialmembrane antigen (EMA).5/18 cases originally diagnosed as 'anaplastic carcinoma'and anaplastic carcinoma and ML to be excluded', showed positive staining for LCAand negative for EMA; whereas 3 cases originally diagnosed as 'malignancy withtype unclassified'turned out to be ML, with the relevant assay performed.
出处
《肿瘤》
CAS
CSCD
北大核心
1992年第3期103-104,共2页
Tumor
